New development of oHSV for cancer treatment
Sponsored by: Open Therapeutics™

  1. Home
  2. Grants
  3. New development of oHSV for cancer treatment

Abstract:

Sponsored by Open Therapeutics. Matching funds are being sought. Details coming soon...

This grant will award up to $3,000.00 USD or 30000.00 SCI towards the winning proposal(s).

Proposals that utilize the following Technologies will be considered:

Therapod project tittle oncolytic herpes simplex virus (oHSV)-rQT3 against cancer cells

Grant issuance date:

2022-02-22 09:15 UTC

Proposal submissions:

Ended on 2022-05-15 15:26 UTC

Voting Period:

Are being accepted till 2022-06-15 00:00 UTC